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Summary 
Monocyte recruitment  and adherence  are important events in inflammatory and vascular dis- 
eases.  Here,  we evaluated the actions of lipoxin A 4 (LXA4) and LXB4, a series of lipoxygenase 
products  from  arachidonic  acid  generated  by  cell-cell  interactions,  on  human  monocytes. 
LXA  4 and LXB  4 (10 -7 M)  each increased monocyte migration in chamber chemotaxis assays 
and, in migration under agarose, exhibited chemotactic indices similar to those of the chemo- 
tactic peptide formyl-methionyMeucyl-phenylalanine at  10-1~  -8 M  and to the chemokine 
macrophage inflammatory protein-lot (MIP-lot) at 10-s-10 -7 M  with a rank order of potency: 
Monocyte  chemotactic  protein-lot  ~LXA  4  ~  LXB  4  ~  MIP-lot.  Lipoxins  also  stimulated 
monocyte adherence to laminin.  In addition, human monocytes rapidly transformed ERA  4 and 
LXB  4 to several metabolites.  LXB  4 (>80%)  was converted within 30 s to new products,  in a 
trend similar to that of LXA  4. The novel monocyte-derived LXB  4 products were identified as 
5-oxo-6,7-dihydro-LXB  4 and 6,7-dihydro-LXB4, indicating a role for site-selective  dehydro- 
genation and reduction.  Unlike monocytes, intact polymorphonuclear leukocytes (PMN)  did 
not metabolize LXA  4 in significant quantities, and only r  of exogenous LXB  4 was c0-oxi- 
dized to 20-OH-LXB  4 and 20-COOH-LXB 4 by PMN.  To determine  if lipoxin conversion 
altered bioactivity, we  evaluated the  actions of these  metabolites  on monocytes. Each of the 
novel products of LXA  4 and LaB 4 from monocytes, namely oxo- and dihydrolipoxins, were 
essentially inactive in stimulating monocyte adherence.  In contrast, the m-oxidation products of 
LXB  4 isolated from PMN were equipotent with LXB  4 for monocyte adherence.  Dehydroge- 
nation  of ERA  4 in monocytes appears to be carried out by a  15-hydroxyprostaglandin dehy- 
drogenase, which is present in human monocytes as determined by reverse transcription PCR 
and Western blots. Together,  these results provide the first evidence that ERA  4 and LXB  4 are 
both potent stimulants for migration and adherence of human monocytes. Moreover, they un- 
derscore the importance of the major route of lipoxin metabolism in leukocytes, namely, the 
rapid dehydrogenation and inactivation carried out by monocytes. 
A 
ctivation of peripheral blood leukocytes, leading to ad- 
herence to damaged vessel walls and extravasation into 
surrounding tissue,  is an important  event in many inflam- 
matory and vascular diseases  (1, 2). Leukotriene B 4 CLTB4)  1, a 
1Abbreviations used in  this paper: BCECF-AM, [2'-7'-bis-(carboxyethyl)- 
5(6')-carboxyfluorescein acetoxymethyl]-ester; CR, carbonyl reductase; 
GAPDH, glyceraldehyde-3-phosphate  dehydrogenase; HETE, hydroxy- 
eicosatetraenoic acid; LTB4, leukotriene B4; LXA4, lipoxin A4; LXB4, 
lipoxin B4; MCP-1, monocyte Chemotactic protein-I;  MIP-let, macro- 
phage inflammatory protein-la; NAD +, nicotinamide adenine dinucle- 
otide; NADP, nicotinamide adenine dinucleotide phosphate; 15-PGDH, 
15-hydroxyprostaglandin  dehydrogenase;  RP-HLPC, reverse phase HPLC; 
RT, reverse transcription. 
lipoxygenase product of arachidonic acid,  is a potent acti- 
vator of PMN chemotaxis and adherence (3). Another class 
of lipoxygenase products from cell-cell interactions,  the li- 
poxins, display selective activities on human leukocytes that 
have  been  shown  to  be  both  stimulatory  and  inhibitory, 
depending on the  cell type involved.  In human PMN,  li- 
poxin A 4 (LXA4) (10-9-10 .7 M) induces chemokinesis but 
inhibits  chemotaxis  toward  LTB  4  and  FMLP  (4).  LXA  4 
(10 -8 M) also inhibits  FMLP-stimulated PMN transmigra- 
tion across intestinal  epithelium  (5).  In human eosinophils, 
tXA 4  also  inhibits  chemotaxis  toward  both  FMLP  and 
platelet activating factor (6). Lipoxin B 4 (LXB4) (nanomolar 
range) is reported to stimulate colony formation and differ- 
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kocyte populations  (7).  These findings indicate that  LXA  4 
and LXB  4 each  display selective actions on human leuko- 
cyte subtypes. 
The major routes of further metabolism, which regulate 
eicosanoid bioactivity in human  tissues,  include ~-oxida- 
tion,  t0-oxidation,  and  dehydrogenation  (for  review  see 
reference 8).  Our laboratory has demonstrated that human 
peripheral  blood  monocytes  transform  LXA  4  to  15-oxo- 
LXA  4,  13,14-dihydro-15-oxo-LXA  4,  and  13,14-dihydro- 
LXA  4 (9), which suggested that lipoxins, or their metabolites, 
may have bioactions in monocytes and that the transforma- 
tion may alter lipoxin bioactivity to  enhance  or  decrease 
their potency. The present results document previously un- 
recognized bioactivities of both LXA  4 and LXB  4 in human 
monocytes and establish the importance of lipoxin further 
metabolism in these cells. 
Materials and Methods 
Cell Isolation.  Human monocytes were isolated using a modi- 
fication of the  method  of Denholm and Wolber  (10).  Briefly, 
whole blood collected in acid citrate dextrose from healthy vol- 
unteers was centrifuged (200 g) at 25~  for 15 min for removal of 
platelet-rich plasma.  The  cells  were  then  layered over  Ficoll- 
Hypaque  (LSM;  Organon Teknika,  Durham,  NC)  and  centri- 
fuged (500 g) at 25~  for 35 min. The mononuclear cell layer was 
collected,  washed  once,  and resuspended  in  PBS  2-  containing 
0.l% BSA. 8 nil ofa Percoll: 10X  HBSS (10: 1.65)  mixture was 
added to 4 ml mononuclear cells in 10 X  1.5-cm round-bottom 
silanized polypropylene tubes and centrifuged (370 g) at 25~  for 
30 min. Monocytes were collected from the upper 5 mm of the 
gradient and  washed  before  counting and  viability assessment. 
Human PMN were isolated by the B6yum method (11) from pe- 
ripheral blood obtained from healthy volunteers. Cells were iden- 
tified by Wright-Giemsa staining. The monocyte population was 
>90% with <10% contaminating lymphocytes, and PMN were 
>95% pure. Both monocytes and PMN contained platelets at ap- 
proximately a 2:1 ratio ofplatelets to leukocytes. Viability of cells 
in all reported  experiments was  >95%  as  determined by  their 
ability to exclude trypan blue. 
Chemotaxis.  Chamber chemotaxis was evaluated using a mi- 
crochamber  technique  according  to  the  method  of Falk  et  al. 
(12).  Briefly, monocytes were isolated as above and resuspended 
at  5  X  106/mi  in PBS  2+.  Chemoattractant  solution or  vehicle 
(PBS  2+ containing 0.05% ethanol) was added to the lower wells 
of a  48-well  chemotaxis  chamber  (Neuro  Probe,  Cabin John, 
MD).  A  polycarbonate  membrane  with  5-lxm  diameter  pores 
(Poretics  Corp.,  Livermore,  CA)  was  layered  on  top  of  the 
chemoattractant  wells,  and  monocytes  were  added  to  the  top 
wells. After incubation for 90 min at 37~  the membrane was 
removed,  scraped  of cells  from  the  upper  surface,  and  stained 
with  modified  Wright-Giemsa  stain.  Cells  that  had  migrated 
through the membrane in four high-power fields were counted. 
Chemotaxis  under  agarose  was  performed  using  conditions 
from the methods ofA1-Sumidaie et al. (13).  Briefly, agarose mi- 
gration  plates  were  prepared  using  0.75%  agarose  (Type  IV; 
Sigma Chemical Co.,  St.  Louis, MO)  dissolved in HBSS  2+  (pH 
7.0) with 10% human serum, which was added to 60-mm diame- 
ter tissue culture dishes.  Chemotactic agents and HBSS  2+ (10 p,1) 
were added to each of the inner and outer wells, respectively, and 
the plates were incubated at 37~  in humidified air with 5% CO 2 
for 45 rain. Fluid was aspirated from all wells and replaced with 
fresh chemoattractant or HBSS  2+, and cells  (106 in 10  Ixl) were 
added to the middle wells of each set. The plates were then incu- 
bated at 37~  in humidified air with 5% CO2 for 18-20 h, after 
which the cells were fixed with glutaraldehyde and stained with 
modified Wright-Giemsa stain.  Cell migration was  quantitated 
by measuring the linear distance the  cells  had moved from  the 
margin of the wells toward the chemoattractant (D, directed mi- 
gration)  and away from it (C, random migration) as well as to- 
ward (A) and away (/3) from vehicle control wells. The chemo- 
tactic index (D/C) and migration index (D/[(A  +  /3)/2])  were 
calculated for each chemoattractant as in Colgan et al. (14). 
Laminin  Adhesion.  Isolated  monocytes  were  suspended  in 
PBS  2- (4  X  106/m]) and [2'-7'-bis-(carboxyethyl)-5(6')-carboxy- 
fluorescein  acetoxymethyl]-ester  (BCECF-AM;  Calbiochem 
Corp., La Jolla, CA) was added (1.0 IzM) and incubated with cells 
for 20 min at 37~  Cells were washed and resuspended (3.3  ￿ 
106/ml)  in PBS  2+  containing 0.1% BSA.  90-1*1 aliquots of cells 
were  added to each well of a 96-well flat-bottom tissue culture 
plate  coated  with  laminin (Collaborative Biomedical Products, 
Bedford, MA) and allowed to settle for 10 min. 10 Ixl of agonist 
or vehicle was added to each well, and plates were incubated at 
37~  for  20  min.  After  incubation, wells  were  aspirated  and 
washed once with PBS  2+ containing 0.1% BSA. Cells adhering to 
the wells were solubilized with 0.025 M  NaOH containing 0.1% 
SDS  (100  Ixl), followed by fluorescence quantitation on a plate 
fluorimeter. 
Products of Lipoxin  Metabolism: Isolation and Identification.  For 
generation and isolation of the oxo- and dihydro- metabolites of 
lipoxins, monocytes were  resuspended at  125  X  10  6 cells/5 ml 
PBS  2+ and incubated with 500 ng LXA  4 and 100,000 dpm  [11, 
12-3H]LXA4, as in Serhan et  al.  (9),  or  1.0 Ixg LX-B4 at  37~ 
~0-Oxidation products  of LXA  4 and LXB  4 were  obtained from 
PMN resuspended at 150  X  106 cells/3 ml PBS  2+ and incubated 
with 2.0 Ixg LXA4 or LXB  4 at 37~  Incubations were stopped at 
0.5,  1, 5, and/or 20 min with cold methanol containing PGB2 as 
an  internal  standard.  Products  were  extracted  and  chromato- 
graphed as described in Serhan et al.  (9).  To obtain quantities of 
compounds sufficient for structural identification and biological 
assays,  multiple incubations (n  =  4)  were  extracted,  stored  at 
-20~  and pooled before reverse phase (1KP)-HPLC separation. 
The HPLC system consisted of a gradient dual pump (LKB-Phar- 
macia, Piscataway, NJ) equipped with an Altex Ultrasphere-ODS 
(4.6  mm X  25  cm)  column (Alltech Assoc.  Inc., Deerfield, IL), 
flow rate  1 ml/min, eluted  (T0-20 rain) with  methanol/HzO/ 
acetic acid  (65:35:0.01,  vol/vol/vol) and methanol~acetic  acid 
(99.99:0.01,  vol/vol) in a linear gradient (20-45  min) that was 
used to quantitate and recover lipoxin-derived metabolites. On- 
line spectra were recorded using a diode array detector (1040M 
series  II;  Hewlett-Packard  Co.,  Palo  Alto,  CA)  equipped with 
HPLC 3D  ChemStation  software  (Hewlett-Packard  Co.).  Gas 
chromatography/mass spectroscopy was performed  as in Serhan 
et  al.  (9)  using  a  mass  selective  detector  quadrupole  (model 
5971A;  Hewlett-Packard  Co.)  and  gas  chromatograph  (model 
5890; Hewlett-Packard Co.)  using a HP-Ultra 2 column (cross- 
linked 5% phenyl methyl silicone gum phase; 25 cm X  0.2 mm 
￿  0.33  ~m). Before analysis,  products were  treated with diazo- 
methane and converted  to  their trimethylsilyl derivatives using 
bis(trimethylsilyl)  trifluoroacetamide. 
Monocyte-derived  LXA  4  metabolites  15-oxo-LXA  4,  13,14- 
dihydro-15-oxo-LXA4,  and  13,14-dihydro-LXA  4 were  isolated 
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consistant  with  reported  data.  The  monocyte-derived  LXB  4 
products were identified using the criteria of Ho and Wong (15) 
for  6,7-dihydro-LXB  4  that  was  identified  from  potatoes.  This 
product had an  HPLC retention time of 2.5  min and showed a 
UV spectrum with triplet maxima at 258,  268,  and 279 nm (+4 
rim,  recorded on line). The mass  spectrum of the Me3Si deriva- 
tive of the  methyl  ester  gave prominent  ions  at  m/z  203  [base 
peak,  Me3SiO=CH-CH(CH2)3-COOMe]  and  173  [Me3SiO = 
CH(CH2)4CH3].  The  5-oxo-6,7-dihydro-LXB  4  also  displayed 
triplet absorbance at UV kma  x of 259, 269, and 280 nm, and had a 
RP-HPLC retention time of 35.6 rain. Its methyl ester Me3Si de- 
rivative was identified with prominent ions at m/z 208 [Me3SiO = 
CH(CH)6(CH2)2],  173 [Me3SiO=CH(CH2)4CH3],  129 [base peak, 
O=C(CH2)3COOMe]  and 118. 
PMN-derived  products  of LXB  4  were  identified  as  in  Mi- 
zukami  et  al.  (16,  17).  Briefly,  the  UV  chromophores  of the 
(0-oxidation products, 20-OH-LXB 4 and 20-COOH-LXB 4, were 
essentially identical to  LXB4, showing UV )tm~  x at 287,  301,  and 
315  nm  (+_4 nm).  The  tLP-HPLC  retention  time  of 20-OH- 
LXB 4 was 3.6 min, and the mass  spectrum of the Me3Si methyl 
ester  derivative was  characterized  by  major  ions  as  reported  in 
Mizukami et al.  (16).  20-COOH-LXB 4 eluted from this HPLC 
system at 2.9  min and its Me3Si methyl ester derivative showed 
major ions in its mass spectrum in agreement with those recently 
reported by  Mizukami  (17),  namely m/z  203  (base  peak),  217, 
409 (M+-217), 423 (M+-203),  and 626  (M+). 
Reverse  Transcriptase  PCR.  Total  tLNA  was  isolated  from 
monocytes using differential extraction  of tLNA with phenol at 
an  acidic  pH  (18),  and  preparations  with  a  RNA/protein  ratio 
>2 were used for poly(A) + tLNA selection. Poly(A) + tLNA was 
selected by affinity chromatography  on oligo(dT)-cellulose (18). 
Poly(A) + 1KNA (1  b~g) from monocytes was reverse transcribed to 
cDNA in 20 btl total volume using avian leukemia virus reverse 
transcriptase  (RT),  RNAsin  |  (10 U), MgC12  (5 raM),  oligo(dT) 
primer  (0.5  I.Lg), dNTPs  (1  mM),  and  buffer  with  a  1KT  kit 
(Promega  Corp.,  Madison,  WI)  and  incubated  for  1 h  at  42~ 
The reaction was stopped by heating to 100~  for 10 rain, imme- 
diately followed by storage on ice. Specific primers were designed 
for  15-hydroxyprostaglandin  dehydrogenase  (15-PGDH)  and 
carbonyl reductase (elK) using Sequence Analysis Software Pack- 
age (Genetics Computer Group, University of Wisconsin, Madi- 
son, WI) and published sequences of the two genes (19,  20). The 
primers  used  for  glyceraldehyde-3-phosphate  dehydrogenase 
(GAPDH) were as published in Hla and Maciag (21).  PC1K am- 
plifications were performed using cDNA (5  b~l) with either  15- 
PGDH-,  GAPDH-,  or  CR-specific  primers  (Integrated  DNA 
Technologies,  Inc.,  Coralville, IA).  The  sequences  of the  sense 
and  antisense  primers  for  PGDH  were:  PGDH  sense,  5'-CAC 
GTG AAC GGC AAA GTG-3'; PGDH antisense, 5'-GCA TTA 
TTG  ACC  AAA  ATG  TCC  A-3'.  The  sequences  for  the 
GAPDH primers, which were used as a control, were: GAPDH 
sense, 5'-CCA CCG ATG GCA AAT TCC ATG GCA-Y; and 
GAPDH antisense,  5'-TCT AGA CGG CAG GTC AGG TCC 
ACC-3'.  CR  primers  were:  CR  sense,  5'-CCT  GAG  CCA 
GGT  CTG  TTC  TC-3';  and  C1K  antisense,  5'-GGG  TGT 
GGG  ATC  AGC  AAC-Y.  Sequence  amplification  was  per- 
formed in a  total volume of 25  bd,  using 0.5  I~M each of sense 
and antisense primers,  dNTPs  (0.2  raM),  MgCI  2 (1.5  raM),  Taq 
polymerase (1.5  U) (Promega Corp.) and 10X  buffer (2.5  btl) in- 
cluded with the enzyme. The reactions were amplified by 35 re- 
petitive cycles of denaturation at 94~  for 30 s, annealing at 55~ 
for 1 rain, and extension at 72~  for 2 min. Amplified DNA was 
electrophoresed in 2% agarose gels containing ethidium bromide, 
and bands were photographed. 
SDS-PAGE  and  Immunoblotting.  Monocytes were suspended 
in  PBS  2-  (50  X  106  cells/m])  and  sonicated  in  an  ice bath  for 
three bursts  of 30  s each  (Branson  Sonifier 250;  Branson  Sonic 
Power Co., Danbury,  CT). The  100,000 g supernatant  was used 
in SDS-PAGE and immunoblots for 15-PGDH. Human placenta 
(1 g) was cut into pieces ,'~1 mm  3, 3 ml PBS  2- was added to the 
tissue, and  1.5-ml aliquots were homogenized 4  5<  2 rain at 0~ 
at the highest setting of a tissue homogenizer (Talboys Instrument 
Corp.,  Montrose,  PA).  Supernatants  used  for  SDS-PAGE  and 
immunoblotting were prepared by centrifuging the homogenate 
at 10,000g for 20 rain at 4~ 
Proteins  were  fractionated  by  SDS-PAGE  according  to  the 
method of Laemm]i (22).  Electrophoretic transfer of proteins was 
performed as in Towbin et al.  (23),  except polyvinylidine difluo- 
ride (DuPont-NEN, Boston, MA) was used as the transfer mem- 
brane.  15-PGDH  was  visualized using  rabbit  anti-PGDH  anti- 
serum  as  1  ~  antibody  (a  generous  gift  from  Dr.  H.-H.  Tai, 
University of Kentucky,  Lexington,  KY)  and  a  2  ~ peroxidase- 
conjugated goat anti-rabbit IgG (Sigma Chemical Co.), followed 
by  treatment  with  chemiluminescent  reagents  (DuPont-NEN) 
and  exposure  on  radiographic  film  (R.X;  Fuji  Photo  Film  Co., 
Elmsford, NY). 
Statistical  Analysis.  Data  were  analyzed  using  paired  or  un- 
paired Student's t tests, and significance was determined at p  <  0.05. 
Results 
Chemotaxis.  LXA  4 and LXB  4 both proved to be potent 
chemoattractants  for  monocytes  (Fig.  1).  In  chamber 
chemotaxis assays with monocytes,  FMLP is maximally ac- 
tive  at  concentrations  of  10-8-10 -7  M  (24)  and  in  the 
present  experiments,  it  increased  migration  by  4.5  times 
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Figure  1.  LXA  4 and  LXB  4  stimulate  human  monocyte  chemotaxis. 
Chemotaxis  was quantitated in chambers using agonists at equimolar con- 
centrations  (10 -7 M). Values represent mean numbers  (+  SE) of mono- 
cytes that  migrated  through 5-1xm polycarbonate  filters in four standard 
high-power fields after incubation  for 90 min at 37~  for three  separate 
experiments  performed in triplicate. *Denotes values significantly higher 
than vehicle (p <0.05). 
139  Maddox and Serhan gave statistically significant monocyte chemotaxis at  10 -7 M 
that  was  approximately  three  times  greater  than  vehicle 
controls. Next, migration under agarose was used to exam- 
ine concentration dependence of the lipoxin response and 
distinguish chemotaxis from chemokinesis. The use of mi- 
gration under agarose allowed assessment of directed versus 
spontaneous  migration and  also  required  fewer  cells  than 
the chamber system, which permitted direct comparison of 
concentration dependency for both LXA  4 and LXB  4 with 
cells  from  the  same  donor.  The  chemotactic  response  to 
LXA  4 and LXB  4 was concentration dependent from 10 -1~ 
10 -6  M  (Fig.  2).  The  chemotactic  indices  (as  defined  in 
Colgan et al. [14]) for LXA  4 and LXB  4 were comparable to 
that of FMLP from 10-1~  -8 M. Only at 10 -7 M  was the 
chemotactic index of FMLP greater than LXA  4 and LXB4, 
and  at  10 -6  M  FMLP,  this  index  dropped  precipitously, 
whereas with ERA  4 and LXB4,  chemotactic response con- 
tinued to increase. Monocyte migration for LXA  4 was also 
directly  compared  with  human  recombinant chemokines, 
monocyte  chemotactic  protein  (MCP-1)  and macrophage 
inflammatory protein (MIP-lo  0  (R&D Systems, Inc., Min- 
neapolis,  MN)  (Table  1).  The  relative  potency  of LXA  4 
was  equal  to  MIP-lcx  and was  ~1  log less  than MCP-1. 
These data reveal that LXA  4 and LXB  4 are potent activators 
of monocyte  migration at  submicromolar  concentrations, 
comparable  to  equimolar concentrations of the  chemotac- 
tic peptide,  FMLP, and the monocyte chemokines. 
Adherence.  Since  chemotaxis  is  one  of  the  steps  in- 
volved in diapedesis of leukocytes from blood vessels into 
tissue,  it  was  also  of interest to  examine  the  ability of Ii- 
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Figure 2.  Monocyte migration induced by LXA 4 and LaB 4 is concen- 
tration  dependent.  Chemotaxis  toward  lipoxins,  FMLP,  or  vehicle 
(PBS  2+ plus 0.35% ethanol) was quantitated under agarose as described in 
Materials and Methods.  Values are the results from an experiment per- 
formed in quadruplicate and are representative of four separate experi- 
ments. *Denotes values significantly higher than LXA  4 (/o <0.05);  *values 
significantly higher than ERA 4 and  LaB 4  (p  <0.05);  ~values significantly 
higher than FMLP (p <0.05). 
Table 1.  Monocyte  Migration: Comparison of LXA. 
with Chemokines 
Migration index* 
Concentration  MCP- 1  LXA  4  M IP- lo~ 
10 -7 M  2.93 "4- 0.24*  2.61  +  0.46  2.74 +  0.23 
10 -s M  2.56 +  0.56*  2.48 +  0.48  2.61  •  0.12 
*Monocyte migration was measured under agarose as described in Ma- 
terials and Methods. Data represent means +  SE of four separate exper- 
iments, and all values were significantly higher than vehicle control (p 
<0.05). 
*Denotes values significantly higher than LXA  4 at equal concentration 
as determined by paired t test (p <0.05). 
poxins to stimulate another of the components of this pro- 
cess,  namely, adherence of monocytes to a  matrix. Mono- 
cyte adherence  to  endothelial cells is well established,  and 
significant adhesion  to  subendothelial extracellular  matrix 
proteins such as laminin has also been shown (25). To focus 
solely  on  the  impact  of lipoxins  on  monocytes,  we  used 
laminin-coated wells for adherence assays.  In these experi- 
ments,  LXA  4 and LXB  4 were  again compared  with  well- 
established  activators  of  monocyte  adherence,  namely, 
FMLP and LTB 4 (24). At 10 -7 M,  all four agonists signifi- 
cantly increased adherence above vehicle alone and, specif- 
ically,  LX.A  4  increased  monocyte  adherence  by  41.3  -+ 
2.1% and LaB 4 by 52.4  +  15.5%  above controls  (Fig.  3). 
In direct comparison, LTB  4 and FMLP increased monocyte 
adherence by 23.5  +  8.9% and 58.6  +  19.1%, respectively, 
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Figure  3.  LXA 4  and  LXB 4 stimulate human monocyte adherence to 
laminin-coated plates. Cells were labeled with BCECF-AM before incu- 
bation (3 ￿  10  s cells in 100 Ixl) with each compound for 20 rain at 37~ 
Values represent means -4- SE for three separate experiments performed in 
quadruplicate and are expressed as the percentage above vehicle. Adher- 
ence with exposure to vehicle alone was 39.9 +  7.7% (inean 4- SE). All 
agonist values were significantly higher than vehicle (p <0.05). *Denotes 
values significantly higher than LTB  4 (p <0.05). 
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tablished a  time  course  of monocyte  adhesion,  as well as 
concentration  dependence for both LXA  4 and LXB  4.  The 
stimulator,/action of the lipoxins proved to be concentra- 
tion dependent  (Fig. 4),  with the highest activity tested at 
10 -6 M  for both compounds. Minimal monocyte adhesion 
activity was observed at 10 -~~ M  for both  LXA  4  or  LXB  4. 
The  time course of lipoxin-stimulated monocyte adhesion 
showed a rapid increase that was apparent within the first 5 
min  and plateaued between  10  and 20  min  (Fig. 4,  inset). 
This is similar to the time course previously demonstrated 
for  both  LTB 4 and  FMLP  induced  monocyte  adherence 
(24).  These results establish that LXA  4 and LXB  4 can rap- 
idly  and  significantly  stimulate  monocyte  adherence  to 
laminin  which,  at  10 -7  M,  is  not  significantly  different 
from that induced by FMLP, and is greater than the LTB  4 
response (p <0.05). 
Transformation of Lipoxins  by Leukocytes.  Because  intact 
human monocytes transform LXA  4 (9), it was of interest to 
examine the  fate  of LXt34  incubated with  monocytes  and 
determine  whether  further  metabolism  regulated  lipoxin 
bioactivity. Also,  Mizukami  et  al.  (16)  recently  reported 
co-oxidation of LXB  4 by isolated microsomes from human 
PMN.  Therefore,  we directly compared transformation of 
LXA  4 and  LXB  4 by intact human  PMN  and  monocytes. 
Incubation  of monocytes  with  either  LXA  4 or  LXB 4 re- 
sulted  in  rapid  loss  of  the  native  compounds  (Fig.  5). 
Within the first 30  s there was "o80%  conversion of both 
LXA  4 and LXB  4 to several new products. In contrast, with 
intact  PMN,  LXA  4 was  not  appreciably further  metabo- 
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Figure 4.  Concentration dependence of monocyte adherence. Mono- 
cytes were incubated with LXA4 and LXB  4 as in Fig. 3. Values are from 
an experiment performed in quadruplicate and are representative of four 
separate donors. (Inset) Time course of lipoxin-stimulated adhesion. Cell 
incubations performed as in Fig. 3 with lipoxin (10  7 M) were terminated 
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Figure 5.  Time  course of conversion of ERA  4  and  LNB  4 by human 
monocytes versus neutrophils. Lipoxins were added to cell incubations as 
described in Materials and Methods. At the indicated time intervals, ali- 
quots (0.5 ml) were removed, placed in 2 vol cold methanol with internal 
standard (PGB2), extracted, and chromatographed by R_P-HPLC. Values 
are the means from cells obtained from two separate donors and are ex- 
pressed as the percentage of remaining lipoxin. 
lized,  and  in  incubations  with  LXB  4  and  intact  PMN, 
<15% conversion of the native LXB 4 was observed (Fig. 5). 
Next, for evaluation of their biological significance, each 
of the  lipoxin-derived products  from  human  leukocytes 
was  isolated as  described in  Materials and  Methods.  The 
LXA4-derived compounds included 15-oxo-LXA4,  13,14- 
dihydro-15-oxo-LXA4,  and  13,14-dihydro-LXA4,  as  re- 
ported in  Serhan  et  al.  (9).  Products  of LXB  4 from  both 
monocytes  and  PMN  were  separated by  P,.P-HPLC  and 
collected for gas chromatography/mass spectroscopy analy- 
sis and bioassay (see Materials and Methods). LXBa-derived 
metabolites isolated and identified from monocyte incuba- 
tions  were  5-oxo-6,7-dihydro-LXB  4  and  6,7-dihydro- 
LXB  4. We were not able to isolate a sufficient quantity of 
putative  5-oxo-LXB  4 from  intact  monocytes  for  physical 
analysis and bioassays because of its apparent chemical in- 
stability.  Together,  these  results  indicate  that  monocytes 
rapidly convert both LXA  4 and LXB  4 (Fig. 5) by dehydro- 
genation and reduction of a double bond, illustrated in Fig. 
6. Products from PMN  incubations with I.XB  4 were iden- 
tified as 20-OH-LXB 4 and 20-COOH-LXB 4, which indi- 
cates transformation via only co-oxidation by intact PMN 
(Fig. 6). When PMN  were exposed to FMLP  (10 -7 M)  at 
the time ofLXB 4 addition, conversion to co-oxidation pro- 
ducts increased to ~50%  of added LXB  4 (r/  =  2).  In con- 
trast,  addition  of the  Ca  2+  ionophore  A23187  (2.5  btM) 
completely inhibited transformation ofLXB 4 by PMN  (n = 
3),  presumably due  to  competition for co-oxidation at the 
enzyme level with endogenously generated LTB  4,  indicat- 
ing that LTB 4 is the preferred substrate in PMN.  This in- 
terpretation  is  consistent  with  the  K~  values  reported  by 
Mizukami  et  al.  (16).  Thus,  the  major  route  to  lipoxin 
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Figure 6.  Sites  for conversion  of LXAa and 
LXt3  4 by human monocytes  and PMN.  (Left) 
Arrows denote sites of dehydrogenation and re- 
duction ofLXA 4 by monocytes. (Right)  Arrows 
denote  sites in LX.B  4 for dehydrogenation  and 
reduction  (by monocytes) and m-oxidation (by 
PMN). 
transformation in human leukocytes is by dehydrogenation 
and reduction in monocytes. 
Bioactivity ofLipoxin-derived Metabolites.  Each of the fur- 
ther metabolites of lipoxins was  taken for direct  compari- 
son  of its  bioactivity with  that  of the  parent  compound. 
Monocyte  adhesion  to  laminin was  the  assay  selected  for 
these  comparisons because  it required  modest  amounts  of 
the  isolated  compounds  of  interest.  Monocyte-derived 
LXA  4  products  (15-oxo-LXA4,  13,14-dihydro-15-oxo- 
LXA4,  and 13,14-dihydro-LXA4)  did not stimulate mono- 
cyte  adherence  (Fig.  7  A).  Also,  LXB  4  products  from 
monocytes  (5-oxo-6,7-dihydro-LXB 4  and  6,7-dihydro- 
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LX2B4) did not carry biologic activity (Fig. 7  B). In contrast, 
the  m-oxidation  products  isolated  from  PMN  (20-OH- 
LXB  4 and 20-COOH-LXB4)  were  similar to  the  activity 
of native LX]34 in stimulating monocyte adherence to lami- 
nin (Fig.  7  B).  Together,  these  results indicate  that  ERA  4 
and LXB  4 are inactivated by monocytes. Mso,  the  finding 
that  the  to-oxidation products  were  essentially equipotent 
with LXB  4 indicates that the monocyte response is stereo- 
selective. 
Monocyte  15-PGDH.  Conversion of LXA  4  by  mono- 
cytes was  consistent with  the actions of nicotinamide ade- 
nine  dinucleotide  (NAD+)-dependent  15-PGDH.  In  this 
regard,  LXA  4 competes  (Ki 8.2  +  2.6  I-tM) with  15-S-hy- 
droxyeicosatetraenoic acid (HETE), an established substrate 
of  15-PGDH  (26),  for  dehydrogenase  activity  in  mono- 
cyte/macrophage-differentiated HL-60 cells (9), which dis- 
play  15-PGDH  activity (27).  Based  on the presence  of an 
alcohol  at  carbon  15  in both  lipoxins  and  prostaglandins, 
we  considered  15-PGDH  or carbonyl reductase  (a  nicoti- 
namide adenine dinucleotide phosphate  (NADP+)-depen- 
dent  PG  dehydrogenase)  as  candidates  involved  in  the 
conversion oflipoxins by monocytes. To test this, we eval- 
uated the presence of these enzymes in monocytes via RT- 
PCR  and protein immunoblotting techniques.  The  results 
of RT-PCR  showed  a  distinct band using the  15-PGDH 
primers,  indicating  that  15-PGDH  RNA  is  present  in 
monocytes,  as  was  the  control  enzyme,  GAPDH  (Fig.  8 
A). Carbonyl reductase primers produced less consistent re- 
Figure  7.  LXA  4 and LXB  4 are inactivated by further metabolism in hu- 
man monocytes. Biologically derived lipoxin metabolites were isolated as 
in Materials and Methods, and each compound (10  -7 M) was incubated 
with cells for 20 min as in Fig. 3. Values are means (-+SE) from four sep- 
arate experiments,  each performed  in quadruplicate.  (A) LXA4-derived 
metabolites from monocytes. Adherence of cells exposed to vehicle alone 
was  40.5  +  15.l%  (mean  +  SE). (B)  LXB4-derived metabolites from 
monocytes (5-oxo-6,7-dihydro-LXB 4 and 6,7-dihydro-LXB4) and PMN 
(20-OH-LXB  4 and  20-COOH-LXB4).  Adherence  of cells exposed to 
vehicle alone was 20.6  +  11.7% (mean "4- SE). *Denotes values signifi- 
cantly higher than vehicle alone (p <0.05). 
Figure 8.  (A) Agarose gel of RT-PCR products from human mono- 
cyte mRNA. Lane 1: Molecular mass marker (qbX174 Haelll digest); lane 
2: GAPDH primers; lane 3: I5-PGDH primers; lane 4: CR primers (no 
band visible). (/3) Western blot analysis of 15-PGDH in human placenta 
and monocytes. Lane 1:50 Ixg cytosolic placental protein; lane 2:100 Ixg 
cytosolic protein from monocytes. Molecular mass markers (kD) are on 
the  left. The  15-PGDH protein  band is 29 kD.  The higher  molecular 
mass bands have been noted previously and are consistent with those pre- 
sumed to be aggregates of the 15-PGDH protein (27). 
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shown in Fig. 8 A), or a very faint band from other donors. 
Because  15-PGDH primers resulted in consistent,  distinct 
bands via 1KT-PC1K, we examined the presence of the 15- 
PGDH  protein  in  monocyte  cytosol by Western  blot.  A 
protein  immunoblot,  using  human  placenta  as  positive 
control, shows a faint band at 29 kD from monocyte cyto- 
sol  (Fig.  8  B).  In addition,  stronger bands were visible at 
,'~  kD  (also  seen in the placenta), which  have been 
previously documented in 15-PGDH immunoblots and are 
attributed  to  incomplete  dissociation  of the  protein  into 
subunits (27).  Taken together, the 1KT-PC1K and immuno- 
blot demonstrate the presence of both 15-PGDH mlKNA 
and imrnunoreactive enzyme in human monocytes. 
Discussion 
Results obtained in these studies demonstrate for the first 
time that both LXA 4 and LXB 4 are potent agonists for hu- 
man monocyte migration and adhesion.  LXA 4 and  LXB4, 
at  submicromolar  concentrations,  stimulate  migration  of 
monocytes in  a  dose range similar to  the  chemoattractant 
peptide FMLP and the monocyte chemokines MCP-1  and 
MIP-10t  (Figs.  1 and  2,  Table  1).  Both  LXA 4 and  LXB 4 
also  stimulate  adherence  of monocytes to  laminin-coated 
plastic  in  a  concentration-dependent  manner  and  were 
equipotent  with  FMLP  and  LTB  4  (Figs.  3  and  4).  Both 
LXA 4 and LXB 4 were  subject to rapid further metabolism 
by  human  monocytes  and  were  only  minimally  trans- 
formed by intact PMN (Fig.  5). Direct comparison of both 
LXA 4- and LXB4-derived monocyte products in monocyte 
adherence revealed that the novel products of both lipoxins 
did not carry biologic activity (Fig.  7).  These results are in 
sharp contrast to those observed with the quantitatively mi- 
nor  c0-oxidation  products  of LXB 4  isolated  from  PMN, 
namely, 20-OH-LXB  4 and 20-COOH-LXB4, which were 
equipotent with the parent molecule (Fig.  7/3). 
Activation ofmonocyte migration and adherence is rele- 
vant to  numerous inflammatory and vascular diseases,  in- 
cluding  vital  initiating  events  in  atherosclerosis  (1,  2). 
These are also the first steps in normal differentiation and 
maturation of circulating monocytes to tissue macrophages 
(1).  Because our results show that LXA 4 and LXB 4 stimu- 
late both chemotaxis and adherence  of monocytes, it fol- 
lows that lipoxins may play a role in physiologic monocyte 
trafficking  and/or  pathologic  processes  in  which  mono- 
cytes are involved. This is underscored by the finding that 
monocytes inactivate both LXA 4 and LXB 4 (Fig.  8). 
It is of interest to point out that lipoxins activate human 
monocytes and inhibit human PMN activity stimulated by 
other agonists. LXA 4 inhibits FMLP-stimulated transmigra- 
tion of PMN through epithelium (5) and FMLP- or LTB  4- 
induced  PMN  chemotaxis  (4).  In  addition,  LXA  4  and 
LXB  4 inhibit  LTB  4-  and  LTC4-stimulated  adherence  of 
PMN to endothelium (28) and LTDg-stimulated PMN ad- 
herence to mesangial cells (29). The differential action ofli- 
poxins with PMN versus monocytes is intriguing,  Mono- 
cytes and PMN  can respond in  opposing manners to  the 
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same stimulus; for example, phorbol ester stimulates PMN 
adhesion  but  inhibits  monocyte  adhesion  to  endothelial 
cells  (30).  Therefore, it is possible that lipoxins are acting 
via  some  shared  intracellular  second  messengers  in  both 
monocytes  and  PMN,  but  are  eliciting  antithetical  re- 
sponses from the cells. Recently, we identified a previously 
denoted  orphan seven-transmembrane receptor as a high- 
affinity receptor for LXA 4 present in PMN and differenti- 
ated HL-60 cells that has 67% sequence homology with the 
FMLP receptor (31). The presence of this receptor mlKNA 
has also been identified  in human monocytes (32).  These 
results,  together  with  those  presented  here,  suggest  that 
LXA 4 is likely acting via the same receptor in monocytes 
and PMN.  Mobilization  of intracellular  Ca  2+  by lipoxins 
was also  examined,  and we found that,  at submicromolar 
concentrations,  LXA 4  stimulates  increases  in  intracellular 
Ca  2+ (monitored by Fura-2) in both monocytes and THP-1 
cells, but in parallel experiments LXB 4 did not induce a sig- 
nal  of comparable magnitude  (Romano,  M.,  and  C.  Ser- 
han, manuscript in preparation). This suggests that the post- 
receptor  interactions  in  each  cell  type  may  be  distinct. 
Along these lines, LXB 4 does not bind to the same receptor 
as LXA 4 (31),  and likely has a unique receptor or site of ac- 
tion in monocytes. 
In general, eicosanoids can be rapidly transformed to in- 
crease  or  decrease  their  activity in  target  tissues  (33-35). 
LXA 4  is  metabolized  in  monocytes  by  dehydrogenation 
and reduction (Fig. 6), and the proposed sequence of trans- 
formation  is  LXA4-->15-oxo-LXA4-+13,14-dihydro-15- 
oxo-LXA4-+13,14-dihydro-LXA  4  (9).  Based  on  results 
presented here (see Materials and Methods), it is likely that 
LXB  4 is transformed via a similar pathway (Fig.  8).  There- 
fore,  the  hypothetical  scheme  for  LXB 4  metabolism  in 
monocytes can proceed as follows: LXB4--+5-oxo-LXB4--> 
5 -oxo-6,7-dihydro-LXB4---)6,7-dlhydro-LXB  4  . 
An increase or decrease  in  the bioactivity of individual 
eicosanoid further metabolites can be cell type and/or tis- 
sue  specific.  The LTB  4 metabolites 20-OH-LTB  4 and 20- 
COOH-LTB4, for example, are known to be markedly less 
potent chemoattractants for PMN than LTB  4 (33),  and de- 
hydrogenation of prostanoids is generally thought to be an 
inactivation step (for reviews see references 8 and 35). In con- 
trast, the recently identified 5-oxo-HETE, a dehydrogenase 
product of 5-HETE isolated from PMN,  has been shown 
to  possess  potent  stimulatory  properties  for  PMN  (34). 
LXA 4 and LXB 4 m-oxidation products were isolated from 
microsomes from human PMN  (16,  36,  37)  and rat liver 
cells  (17),  but no evaluation of biological activity of these 
metabolites  was  presented.  These  are  likely  the  lipoxin 
products of the P450 enzyme, which acts on LTB  4 as a pre- 
ferred substrate (16).  These results are the first to compare 
bioactivities of the novel monocyte lipoxin-derived metab- 
olites  and  the  c0-oxidation  products  of lipoxins  with  the 
parent  compounds.  The results clearly show  that  conver- 
sion of LXA 4 and LXB  4 in monocytes by dehydrogenation 
and  reduction  of double  bonds  results  in  inactivation.  In 
contrast,  co-oxidation  of LXB 4  to  20-OH-LXB  4 and  20- 
COOH-LXB  4 causes  no  apparent  change  in  potency  in stimulating  monocyte  adhesion  to  laminin.  These  results 
give clues to the key structural elements of the lipoxin mol- 
ecules  involved  in  recognition  and  activation  of mono- 
cytes; namely,  changes at the m end  (carbon 20)  appear to 
have no effect, but alteration of the hydroxyl groups at C5 
in  LaB 4 or  C15  in  LXA4,  or  reduction  of the  adjacent 
double bond (Fig. 8), results in a loss of activity. These re- 
sults  suggest that the segments of the molecules containing 
the tetraene structures are key in defining bioactivity in the 
monocyte. 
Several  key  enzymes  have  been  identified  that  are  in- 
volved in  the  metabolism  of eicosanoids  via  each  of the 
main  pathways,  including  B-oxidation,  t0-oxidation,  de- 
hydrogenation,  and/or  reduction.  LTB4,  for  example,  is 
converted by m-oxidation in PMN by a cytochrome P450 
enzyme (38). Dehydrogenases are important enzymes cata- 
lyzing the transformation of PGE  2 to its  major metabolite, 
15-keto-PGE  2,  in many different  tissues  (35)  and  in  con- 
verting  5-HETE  to  5-oxo-HETE  in  human  PMN  (39). 
NAD+-dependent  15-PGDH  is  one  enzyme  responsible 
for  this  further  metabolism  of prostanoids  and  has  been 
cloned from human placental tissue  (19). An NADP+-depen  - 
dent prostaglandin dehydrogenase activity is also present in 
placental tissue,  attributed to the somewhat nonspecific ac- 
tivity  of carbonyl  reductase,  which  has  also  been  cloned 
(20).  Both lipoxins  carry C15 alcohol groups (Fig.  6),  and 
in  PMA-differentiated  HL-60  cells,  which  express  15- 
PGDH  (27),  LXA  4 blocked ,'~  of 15-HETE  conver- 
sion  to  15-oxo-HETE  at  equimolar  concentrations  (9). 
Therefore,  we hypothesized that one or both of these  de- 
hydrogenase enzymes could catalyze the formation of oxo- 
lipoxins.  Results  showed  distinct  presence  of 15-PGDH 
mRNA in monocytes (Fig. 8 A, lane 3).  Western blots also 
established  that  15-PGDH protein is transcribed in mono- 
cytes and,  therefore,  is likely to contribute to the metabo- 
lism  of LXA  4 by monocytes.  This  finding  does  not  pre- 
clude the presence of additional,  and/or potentially novel, 
enzymes that can carry out similar transformations.  The C5 
alcohol group ofLXB  4 is less likely to be susceptible to 15- 
PDGH  activity and,  though it  is possible  that  the  unique 
dehydrogenase  that  converts  5-HETE  to  5-oxo-HETE  is 
responsible  (39),  there is a lack of extensive  conversion of 
LX_B  4  to  5-oxo-LXB  4  by  intact  PMN  (Figs.  5  and  6), 
where this eicosanoid dehydrogenase activity was observed. 
The results of this report are the first to describe potent 
actions for LXA  4 and LXB  4 on human monocyte migration 
and  adherence,  and  rapid  metabolic  transformation  by 
monocytes to novel products that do not carry these activi- 
ties.  Monocytes  routinely  migrate  into  normal  tissue  for 
differentiation  into  resident  macrophages,  whereas  PMN 
generally extravasate in response to injury or infection, and 
in  these  scenarios,  PMN  are  immediately  responsive, 
whereas  monocytes migrate  in  at  a  later  stage.  These  dis- 
tinctive  behavior patterns  of monocytes versus PMN  sug- 
gest  that  these  cell  types  respond  uniquely  to  the  same 
stimuli.  This  difference in temporal  response would be an 
ideal setting for the production of lipoxins by PMN inter- 
acting with platelets and endothelium at sites  of inflamma- 
tory or vascular injury.  This  early response phase  (40-42) 
could lead  to  recruitment  of monocytes to  the  same  site, 
but at a later  time point.  Thus,  our results suggest that li- 
poxins generated by PMN-platelet  interactions in vascular 
and/or  inflammatory  diseases  could  recruit  monocytes, 
which then are able to self-limit the reaction by rapid fur- 
ther  metabolism  and  downregulation  of LXA  4 and  LXB  4 
bioactivity. 
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